| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Loss on sale of assets | - | 0 | - | - |
| Interest expense, nonoperating | - | - | - | 20 |
| Changes in fair value of warrant liability and warrant modification expense | - | - | -91 | - |
| Changes in fair value of warrant liability | 9 | 13 | - | - |
| Total other income (expense), net | 78 | -4 | 99 | 34 |
| Loss before income taxes | -647 | -640 | -678 | -754 |
| Income tax expense | - | 0 | - | - |
| Net loss | -647 | -640 | -678 | -754 |
| Less income (loss) attributable to non-controlling interest in joint venture | 6 | 25 | 34 | -61 |
| Net loss attributable to nexgel stockholders | -653 | -665 | -712 | -693 |
| Net loss per common share - basic | -0.08 | -0.09 | -0.09 | -0.11 |
| Net loss per common share - diluted | -0.08 | -0.09 | -0.09 | -0.11 |
| Weighted average shares used in computing net loss per common share diluted | 7,971,299 | 7,654,348 | 7,645,311 | 6,569,403 |
| Weighted average shares used in computing net loss per common share - basic | 7,971,299 | 7,654,348 | 7,645,311 | 6,569,403 |
NEXGEL, INC. (NXGL)
NEXGEL, INC. (NXGL)